Please enable JavaScript
Powered by Benchmark International Archives - Page 404 of 2068 - Matribhumi Samachar English
Tuesday, March 03 2026 | 01:36:38 AM
Home / International (page 404)

International

Search Minerals Announces Shares-for-Debt Transaction

St. Lewis, Newfoundland and Labrador–(Newsfile Corp. – December 3, 2025) – Search Minerals Inc. (TSXV: SMY) (“Search Minerals” or the “Company“) is pleased to announce that it has entered into a transaction with LeadFX Inc. to settle an aggregate of $404,053.73 of outstanding indebtedness (the “Debt“) through the issuance of 808,107 …

Read More »

Focus Graphite Appoints Renowned Battery Executive Dr. Sunho Kang as Strategic Advisor for Cell Technology

Former Apple and Samsung SDI Battery Expert to Guide High-Purity Anode Materials and Dual-Use Next-Generation Cell Platforms. Ottawa, Ontario–(Newsfile Corp. – December 3, 2025) – Focus Graphite Inc. (TSXV: FMS) (OTCQB: FCSMF) (FSE: FKC0) (“Focus” or the “Company“), a leading developer of high-grade flake graphite deposits and innovator of next-generation lithium-ion battery …

Read More »

Triple Point Resources Relaunches Supplier Registration Database to Strengthen Local, Regional and National Partnerships

Newfoundland and Labrador–(Newsfile Corp. – December 3, 2025) – Triple Point Resources Ltd. (“Triple Point” or “the Company”) is pleased to announce the reintroduction of its Supplier Registration Database, now live through the company’s newly updated website. After a period of redevelopment and system upgrades, the form has returned as …

Read More »

Salazar Resources Announces Private Placement

Vancouver, British Columbia–(Newsfile Corp. – December 3, 2025) – SALAZAR RESOURCES LIMITED (TSXV: SRL) (OTCQX: SRLZF) (FSE: CCG) (“Salazar” or the “Company”) announces that the Company has arranged a non-brokered private placement financing (the “Financing“) of up to 11,000,000 shares at a price of $0.13 per share to raise up …

Read More »

Cosmo Announces Breakthrough Phase III Topline Results from Scalp 1 and Scalp 2 for Clascoterone 5% Solution in Male Hair Loss, Showing up to 539% Relative Improvement in Target-Area Hair Count vs Placebo; US and EU Submissions are Underway

Ad hoc announcement pursuant to Art. 53 LR 1,465 patients were randomized into the two identical-in-design clinical studies Scalp 1 (NCT05910450) and Scalp 2 (NCT05914805) Both studies reached statistically significant endpoints in TAHC (Target-Area Hair Count), with one reaching 539% relative improvement to placebo and the second study reaching 168% …

Read More »